logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Blood Advances cover

Blood Advances

IF7.1
Papers6129
Citations23025
Journal Papers 5947
Publication Date
delete
An Electronic Frailty Index Is Associated with Outcomes in Older Adults Receiving CAR-T Therapy
deleteBlood Advances
IF7.1
delete2026-10-06
delete0
deleteOAAI
deleteJustine P. Enns; Mark R. Korst; Nora Horick; Isabel Neckermann; Olivia Y. Cheung; Bharati Kochar; Ariela R. Orkaby; Matthew J. Frigault; Jeremy S. Abramson; Areej El-Jawahri; Richard A. Newcomb; P. Connor Johnson
deleteShare
deleteSave
Cytoreduction in MPN-SVT: Is the Association Causal?
deleteBlood Advances
IF7.1
delete2026-10-06
delete0
deleteOAAI
deleteUfuk Demirci; Ahmet Emre Eşkazan
deleteShare
deleteSave
Late Venous Thromboembolic Events in Survivors of Childhood Cancer: A Report from the St Jude Lifetime Cohort Study
deleteBlood Advances
IF7.1
delete2026-10-05
delete0
deleteOAAI
deleteRohith Jesudas; Lei Wang; Yan Chen; Sedigheh Mirzaei; Siddhant Taneja; Kirsten K. Ness; Matthew J. Ehrhardt; Stephanie B. Dixon; Bonnie Ky; Melissa M. Hudson; Clifford M. Takemoto; Angela Delaney; Daniel M. Green; Daniel A. Mulrooney
deleteShare
deleteSave
Novel KIR2DS4:HLA-B*35 interaction predicts HLA-B*35 positive patient survival post hematopoietic stem cell transplant
deleteBlood Advances
IF7.1
delete2026-10-05
delete0
deleteOAAI
deleteStephen Gottschalk; Ying Li; Subodh Selukar; Alison M Kirk; Swati Naik; Daniel Fürst; Sophie Mannes; Sarah Flossdorf; Jan Beyersmann; Hubert Schezenmeier; Georg-Nikolaus Franke; Paul G Thomas; Brandon M Triplett; Peter J Chockley
deleteShare
deleteSave
Phase 1/2 study of favezelimab plus pembrolizumab in anti–PD-1–naive relapsed or refractory classical Hodgkin lymphoma
deleteBlood Advances
IF7.1
delete2026-10-05
delete0
deleteOAAI
deleteNathalie A. Johnson; David Lavie; Peter Borchmann; Gareth P. Gregory; Alex F. Herrera; Leonard Minuk; Vladan Vucinic; Philippe Armand; Abraham Avigdor; Robin Gasiorowski; Yair Herishanu; Colm Keane; John Kuruvilla; Rachel Marceau West; Pallavi Pillai; Patricia Marinello; John M. Timmerman
deleteShare
deleteSave
The roots run deep in therapy-related myeloid neoplasms
deleteBlood Advances
IF7.1
delete2026-10-04
delete0
deleteOAAI
deleteMaria Creignou; Elsa Bernard
deleteShare
deleteSave
CC-486 plus venetoclax: another step toward oral AML therapy
deleteBlood Advances
IF7.1
delete2026-10-04
delete0
deleteOAAI
deleteKimberly Seymour; Marina Konopleva
deleteShare
deleteSave
Discontinuation of Targeted Therapy in Histiocytic Neoplasms with Durable Responses: the DOTT-HN Study
deleteBlood Advances
IF7.1
delete2026-09-29
delete0
deleteOAAI
deleteXi Yang; Haadi Ali; Dana Bossert; Carla I. Borre; Brinda H. Shukla; Jacquelyn E. F. Speer; Corbin Wright; Fnu Amisha; Samuel Reynolds; Ronald S. Go; Gaurav Goyal; Jithma Abeykoon; Eli Diamond; Asra Ahmed
deleteShare
deleteSave
An Interactive Database of ADAMTS13 Variants Yields Novel Insight into Thrombotic Thrombocytopenic Purpura
deleteBlood Advances
IF7.1
delete2026-09-28
delete0
deleteOAAI
deleteMatthew A. Carter; Imogen I. H. Buckle; Stephen J. Perkins; Marie Scully
deleteShare
deleteSave
Evaluation of Modern Hematology-Oncology Home-Call: Optimizing Patient Care, Physician Wellbeing, and Trainee Education
deleteBlood Advances
IF7.1
delete2026-09-28
delete0
deleteOAAI
deleteSavannah S. Liddell; Rosalyn Marar; Erica Andres; Eric Cao; Caleb Bentz; Ronald S. Go; Aref Al-Kali; William J. Hogan; Amye J. Tevaarwerk; Brittany L. Siontis; Jonas Paludo; Richard C. Godby
deleteShare
deleteSave
Therapeutic timing and molecular properties influence low-molecular-weight heparin (LMWH) efficacy in murine sepsis
deleteBlood Advances
IF7.1
delete2026-09-28
delete0
deleteOAAI
deleteZarafshan Khan; Dhruva J. Dwivedi; Erblin Cani; Angela Bilic; Harman Bhogal; Alessandra Giglia; Jennifer Viksne; Ji Zhou; Manoj Lalu; Asher A. Mendelson; Braedon McDonald; Patricia C. Liaw
deleteShare
deleteSave
Democratizing cancer risk testing in children before alloHCT
deleteBlood Advances
IF7.1
delete2026-09-27
delete0
deleteOAAI
deleteLucy A. Godley; Timothy S. Olson
deleteShare
deleteSave
New views on VUSs in RUNX1-FPD
deleteBlood Advances
IF7.1
delete2026-09-27
delete0
deleteOAAI
deleteAkiko Shimamura; Alan B. Cantor
deleteShare
deleteSave
Thrombophilia testing: does it truly affect risk?
deleteBlood Advances
IF7.1
delete2026-09-26
delete0
deleteOAAI
deleteLisa Baumann Kreuziger; Damon E. Houghton
deleteShare
deleteSave
Beyond hemolysis: redefining pediatric AIHA
deleteBlood Advances
IF7.1
delete2026-09-26
delete0
deleteOAAI
deleteSatheesh Chonat; Neha J. Desai
deleteShare
deleteSave
A CRISPR-Based Humanized Model Reveals Cooperative Role of STAG2 Loss in Familial GATA2-Deficient MDS Progression
deleteBlood Advances
IF7.1
delete2026-09-26
delete0
deleteOAAI
deleteGrace Freed; Miguel Quijada-Álamo; Linda Lee; Ke Wang; Nikita Poddar; Subrina Autar; Saul Carcamo; Persephone Fiore; Emma K. Kim; Isabella G. Martinez; Mimi Zhang; Shayan Saniei; Clifford Chao; Levan Mekerishvili; Zayna Diaz; Sai Ma; Dan Hasson; Elvin Wagenblast
deleteShare
deleteSave
Advancing mortality risk prediction in sickle cell disease through multi-task deep learning models
deleteBlood Advances
IF7.1
delete2026-09-26
delete0
deleteOAAI
deleteGefei Lin; Xin Tian; Nancy Asomaning; Anna Conrey; Colin Wu; Rui Miao; Swee Lay Thein
deleteShare
deleteSave
Phase 1, open-label, multicenter study of sovleplenib (HMPL-523) in patients with relapsed or refractory lymphoma
deleteBlood Advances
IF7.1
delete2026-09-26
delete0
deleteOAAI
deletePaolo Strati; Dominik Chraniuk; Eva González Barca; Sairah Ahmed; Caly Chien; Dawn Bongiovanni; Shivani Nanda; William Schelman
deleteShare
deleteSave
A hemoglobin >120g/L trends toward improved survival without increasing vascular events in ESA-treated MDS patients
deleteBlood Advances
IF7.1
delete2026-09-23
delete0
deleteOAAI
deleteClarissa Skorupski; Lisa Chodirker; Lee Mozessohn; James T. England; James Kennedy; Matthew C. Cheung; Signy Chow; Jennifer Teichman; Nicola Goldberg; Samantha A Hershenfeld; Hubert Tsui; Alex Mamedov; Mohammed Siddiqui; Liying Zhang; Rena Buckstein
deleteShare
deleteSave
Markedly increased risk of myeloid neoplasia amongst clonal hematopoiesis carriers with multiple TET2 mutations
deleteBlood Advances
IF7.1
delete2026-09-23
delete0
deleteOAAI
deleteFabio A. Schwandt; Jake Tobin; Shreyashee Mallik; Rithin Nedumannil; Julian Ronnacker; William G. Dunn; Veselin Manojlovic; Pedro M. Quiros; Sean Wen; Malgorzata Gozdecka; Margarete A. Fabre; Muxin Gu; George S. Vassiliou
deleteShare
deleteSave